Display search results for ** instead (281 products)

Showing 1-10 of 281

This issue of Vital Signs, released on December 31, 2012, provides Frost & Sullivan's perspectives on the NYeC Digital Health Conference in New York during Q4 2012, including top takeaways from this event, as well as an overview of the conference, summary of an interview with NYeC, and a listing of companies comprising the inaugural class of the Ne...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on November 23, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on November 23, 2012, provides an insight in to breast screening against the backdrop of the recent changes in breast density reporting laws in the United States. Additionally, a company spotlight is provided for MinXray. Founded in 1967, MinXray, Inc. is a worldwide provider of transportable x-ray imaging eq...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on November 14, 2012, provides in-depth commentary on the 26th annual scientific meeting of the Association for Vascular Access (AVA) held October 16-19 in San Antonio, Texas.

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on October 22, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

USD 1,500.00

USD 1,125.00 save 25 %

The market opportunity for radiology informatics is dominated by the core image and information management systems. However, several other radiology informatics solutions also contribute to this market opportunity. This market insight aims to provide a top-level view of the total revenue opportunity for radiology informatics solutions along with an...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on October 8, 2012, provides a strategic insight on the use of healthcare information technology in combatting hospital-acquired infections. Additionally, a company spotlight is provided for Hospira. Hospira, Inc.(NYSE: HSP) is a large global supplier of injectable drugs and infusion technologies for hospital...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on September 28, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

USD 1,500.00

USD 1,125.00 save 25 %

The market insight provides market definitions, market segmentation, market trends, market size and growth rates, and key market opportunities for the next decade. Segments of the in vitro diagnostics market include immunochemistry testing, microbiology testing, point-of-care testing, molecular testing, hemostasis testing, self-monitoring of blood ...

USD 1,500.00

USD 1,125.00 save 25 %

This service provides state-of-the-industry insights for companion diagnostic co-development partnerships between drug companies and their diagnostic partners. Topics include drivers for companion diagnostic programs, a comparison of co-development business models, a guide for what drug companies look for in companion diagnostic partners, and an ou...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 1-10 of 281